The global connected injectable drug delivery devices market size valued USD 397.2 million in 2021 and expected to reach USD 4,468.9 million by 2028, exhibiting a CAGR of 35.4% during the forecast period 2022-2028. The injection of medications into the body is known as the drug delivery process. Oral, transdermal, injectable, and carrier-based methods can all be used to give a medication. Injectable Medicine Delivery uses injections to administer a drug to a patient. Injectable medication delivery systems, such as traditional syringes, needle-free injectors, and auto and pen injectors, have been widely used to treat a variety of medical illnesses, including cancer and autoimmune disorders. The advantage of injection-based drug delivery is that the pharmaceuticals have simple access to the systemic circulation and can be absorbed quickly. This type of medication delivery improves the efficacy and speed with which pharmaceuticals reach their intended target. Injections are used to deliver drugs for curative and immunisation purposes. Health care providers frequently use connected injectable drug delivery systems, which allow them to track patient dose trends. These drug delivery systems aid in discovering a patient's concerns about therapy, medicine, and other illness management regimens, all of which are key concerns for the pharmaceutical and health-care businesses. Typically, these gadgets are made with the patient in mind.

View detailed report description here


Due to the growing burden of chronic diseases, benefits, and convenience, the injectable drug delivery devices market is predicted to rise rapidly, resulting in increased demand for self injectors and expansion of the biologics market, resulting in higher demand for injectors. The rising prevalence of chronic diseases has resulted in an increase in overall syringe usage, particularly disposable syringes. Cardiovascular illnesses, obesity, and diabetes have been found to be the leading causes of death due to chronic diseases. As population increase is believed to be the most significant factor in developing places, this is likely to have the greatest impact on emerging countries. There are currently a large number of medications and therapies available to treat these chronic illnesses. However, in the treatment of any chronic illness, the use of syringes is unavoidable. Syringes can be used to collect samples during diagnosis or as part of a treatment programme for osteoarthritis. As a result, the rise in the prevalence of chronic diseases is likely to fuel the market's expansion. Other factors driving the market's growth include technical developments, improved patient compliance, favourable reimbursement policies, and the rise of biologics in the pharmaceutical sector.

Based on route of administration, the connected injectable drug delivery devices market is fragmented into injectable drug delivery, oral drug delivery, topical drug delivery, ocular drug delivery, nasal drug delivery, pulmonary drug delivery, transmucosal drug delivery, implantable drug delivery. Based on patient care setting, the connected injectable drug delivery devices market is categorized into hospitals, ambulatory surgery centers or clinics, diagnostic centers, home care settings, others. Based on application, the connected injectable drug delivery devices market is classified into cancer, infectious diseases, diabetes, cardiovascular diseases, respiratory diseases, autoimmune diseases, central nervous system disorders, others.

Due to factors such as an increase in biologics in the drug delivery market, rising incidences of chronic diseases such as cancer, respiratory allergies, and diabetes, growing patient compliance to inventing drug delivery advancements, and the presence of a large number of notable players in this region, North America dominates the connected injectable drug delivery devices market. Because of the rising occurrences of chronic diseases such as cardiovascular diseases, diabetes, cancer, and other disorders, Asia-Pacific is likely to develop rapidly throughout the forecast period, driving the drug delivery devices market.

Request sample report at                                 

Some of the major key players in the connected injectable drug delivery devices market are Ypsomed Holdings, Unolife Corporation, Quio Technologies, Phillips-Medisize Corporation, SHL Group, Biocorp, Haselmeier Inc., West Pharmaceutical Services Inc.

About Precision Business Insights: 
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.



Mr. Satya

Precision Business Insights| Toll Free: +1 866 598 1553

Email: [email protected]
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: | D U N S® Number: 852781747